Nektar Therapeutics (NKTR): Price and Financial Metrics

NKTR POWR Grades

• Quality is the dimension where NKTR ranks best; there it ranks ahead of 52.96% of US stocks.
• The strongest trend for NKTR is in Stability, which has been heading down over the past 179 days.
• NKTR's current lowest rank is in the Sentiment metric (where it is better than 2.29% of US stocks).

NKTR Stock Summary

• Nektar Therapeutics's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 13.94% of US listed stocks.
• Of note is the ratio of Nektar Therapeutics's sales and general administrative expense to its total operating expenses; merely 9.97% of US stocks have a lower such ratio.
• Revenue growth over the past 12 months for Nektar Therapeutics comes in at -33.36%, a number that bests only 5.13% of the US stocks we're tracking.
• Stocks that are quantitatively similar to NKTR, based on their financial statements, market capitalization, and price volatility, are MORF, CARA, MRTX, CCCC, and FATE.
• NKTR's SEC filings can be seen here. And to visit Nektar Therapeutics's official web site, go to www.nektar.com.

NKTR Valuation Summary

• In comparison to the median Healthcare stock, NKTR's price/sales ratio is 137.89% higher, now standing at 27.
• NKTR's price/sales ratio has moved up 13.4 over the prior 243 months.
• Over the past 243 months, NKTR's price/earnings ratio has gone down 2.7.

Below are key valuation metrics over time for NKTR.

NKTR Growth Metrics

Its 2 year cash and equivalents growth rate is now at 552.31%.
• Its 4 year revenue growth rate is now at -24.27%.
• Its 5 year revenue growth rate is now at -24.27%.

NKTR's revenue has moved down $1,081,620,000 over the prior 34 months.

The table below shows NKTR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	101.907	-412.66	-523.837
2021-09-30	100.36	-359.756	-495.395
2021-06-30	105.472	-311.295	-474.275
2021-03-31	125.989	-312.297	-428.756
2020-12-31	152.915	-313.287	-444.44
2020-09-30	163.315	-339.876	-440.675

NKTR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NKTR has a Quality Grade of C, ranking ahead of 63.19% of graded US stocks.
• NKTR's asset turnover comes in at 0.072 -- ranking 285th of 682 Pharmaceutical Products stocks.
• CALA, ACOR, and CGEN are the stocks whose asset turnover ratios are most correlated with NKTR.

The table below shows NKTR's key quality metrics over time.